Acute Treatment of Shingles
The recommended first-line treatment for acute shingles is oral acyclovir 800 mg five times daily for 7-10 days, which should be initiated within 72 hours of rash onset for maximum efficacy. 1
Antiviral Medication Options
First-line options:
- Acyclovir: 800 mg orally 5 times daily for 7-10 days 1
- Valacyclovir: 1000 mg orally 3 times daily for 7 days 2
- Alternative dosing: 1.5 g twice daily (may improve compliance) 3
- Famciclovir: 500 mg orally 3 times daily for 7 days 2
Treatment timing:
- Initiate therapy as soon as possible, ideally within 48 hours of rash onset 1
- Treatment started within 72 hours significantly reduces:
- Time to last new lesion formation
- Loss of vesicles
- Full crusting
- Pain during treatment 1
Special Patient Populations
Renal Impairment
Dosage adjustment required based on creatinine clearance:
Acyclovir dosing:
- CrCl >25 mL/min: 800 mg every 4 hours, 5 times daily
- CrCl 10-25 mL/min: 800 mg every 8 hours
- CrCl <10 mL/min: 800 mg every 12 hours 1
Valacyclovir dosing:
- CrCl ≥30 mL/min: No adjustment needed
- CrCl 10-29 mL/min: 500 mg every 24 hours
- CrCl <10 mL/min: 500 mg every 24 hours 1
Immunocompromised Patients
- May require longer treatment duration
- Closer monitoring recommended
- Consider intravenous acyclovir
- Consider temporary reduction in immunosuppressive medication if applicable 1
Children
- For children <45 kg: Acyclovir 20 mg/kg body weight (maximum 800 mg/dose) orally 4 times daily for 7-10 days 1
HIV-infected Patients
- Higher oral doses may be required, especially with CD4+ counts <200 cells/µL 1
Treatment Duration
- Continue treatment until all lesions have scabbed, typically 7-10 days 1
- Extended treatment (21 days vs. 7 days) offers only slight additional benefits and is generally not recommended 4
Pain Management
For pain associated with shingles:
- Topical anesthetics (e.g., lidocaine 2%)
- Oral analgesics following WHO pain ladder
- Keep lesions clean and dry 1
Clinical Pearls and Pitfalls
Common Pitfalls:
- Delayed treatment initiation: Starting treatment after 72 hours significantly reduces efficacy, though some benefit may still be observed 2
- Inadequate dosing: Using lower doses (e.g., acyclovir 400 mg five times daily) has been shown to be less effective than the recommended 800 mg dose 5
- Failure to adjust for renal function: Can lead to toxicity in patients with impaired renal function 1
Important Considerations:
- Corticosteroids (e.g., prednisolone) provide only modest additional benefit in acute phase and do not reduce postherpetic neuralgia risk 4
- Valacyclovir and famciclovir have better bioavailability than acyclovir, allowing for less frequent dosing and potentially better compliance 2
- Treatment should continue until all lesions have scabbed, even if this exceeds the standard 7-10 day period 1
Monitoring and Follow-up
- Monitor for resolution of cutaneous lesions
- Assess for adequate pain control
- Watch for development of complications (e.g., postherpetic neuralgia, ocular involvement)
- Ocular involvement merits referral to an ophthalmologist 6